Home    Back

Cdca    (DrugBank: CDCA)

1 disease
IDDisease name (Link within this page)Number of trials
263Cerebrotendinous xanthomatosis1

263. Cerebrotendinous xanthomatosis    [ 5 clinical trials,   10 drugs,   (DrugBank: 2 drugs),   2 drug target genes,   4 drug target pathways]
Searched query = "Cerebrotendinous xanthomatosis", "27-hydroxylase deficiency", "CYP27 deficiency"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 5 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04270682
(ClinicalTrials.gov)		January 31, 202012/2/2020Study to Evaluate Patients With Cerebrotendinous XanthomatosisA Phase 3 Study to Evaluate the Effects of Chenodeoxycholic Acid in Adult and Pediatric Patients With Cerebrotendinous XanthomatosisCTXDrug: Blinded CDCA 250 mg TID;Drug: Placebo;Drug: Open-Label CDCA 250 mg TID;Drug: Rescue Medication CDCA 250 mg TID;Drug: CDCA Weight-Based Dose TIDTravere Therapeutics, Inc.NULLRecruiting1 MonthN/AAll12Phase 3United States